KVK-Tech Recalls Benzphetamine Hydrochloride Tablets Due to Cosmetic Scuffing
KVK-Tech, Inc. is recalling specific lots of Benzphetamine Hydrochloride Tablets due to cosmetic scuffing marks on the tablets.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 1/5 (Low).
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III and involves a cosmetic defect (scuffing marks) with no reported health hazards, fitting the 'Low' severity criteria for cosmetic defects.
Plain-English summary
KVK-Tech, Inc. is voluntarily recalling 9,360 bottles of lot # 12825A and 7,284 bottles of lot # 12937A of Benzphetamine Hydrochloride Tablets, 50 mg, 30-count bottles. The recall is due to the presence of scuffing marks on the tablets, which is a cosmetic defect.
The affected product is prescription-only and was distributed nationwide. The bottles have an expiration date of 8/18. The FDA has classified this recall as Class III, indicating that the defect is unlikely to cause adverse health consequences.
Consumers who have these specific lots of medication should stop using them and contact their pharmacist or healthcare provider for guidance on replacement or disposal.
The recalled product
- Product
- Benzphetamine Hydrochloride Tablets, 50 mg, 30-count bottle, RX only, Mfd by: KVK-TECH, INC., Newtown, PA 18940, NDC 10702-0040-03
- Manufacturer
- KVK-Tech, Inc.
- Category
- Drug — Prescription Medication
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #: 12825 A
- 12937A
- Exp 8/18
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · KVK-Tech, Inc.
See all →- ModeratePhentermine Hydrochloride Capsules 30mg Recalled for cGMP Deviations
FDA (Drugs) · 2025-05-28
- ModerateIndomethacin Extended-Release Capsules Recalled for cGMP Deviations
FDA (Drugs) · 2025-05-28
- SevereBetaxolol Hydrochloride tablets recalled due to oxycodone contamination
FDA (Drugs) · 2023-10-25
- SevereAtovaquone Oral Suspension Recalled for Temperature Abuse
FDA (Drugs) · 2021-09-01
- ModerateKVK-Tech Recalls Hydrocodone and Homatropine Tablets for Impurity Failures
FDA (Drugs) · 2021-05-26
Same hazard · cosmetic defect
See all →- ModerateICU Medical Recalls Oncology Sets with Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
- ModerateICU Medical Recalls Oncology Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
- ModerateICU Medical Recalls IV Administration Sets with Drip Chamber Specks
FDA (Devices) · 2026-09-23
- LowNilotinib capsules recalled after failing appearance tests at six months
FDA (Drugs) · 2026-03-11
- LowNilotinib 200 mg capsules recalled after failing appearance tests
FDA (Drugs) · 2026-03-11
Similar recalls
- LowKVK-Tech Recalls Benzhydrocodone and Acetaminophen Tablets Due to Impurity
FDA (Drugs) · 2021-01-20
- LowKVK-Tech Recalls Phentermine Hydrochloride Capsules Due to Impurity Failures
FDA (Drugs) · 2015-09-02
- ModeratePhentermine Hydrochloride Capsules 30mg Recalled for cGMP Deviations
FDA (Drugs) · 2025-05-28
- LowKVK-Tech Recalls Methylphenidate Hydrochloride Oral Solution Due to Foreign Particles
FDA (Drugs) · 2019-10-23
- SevereBetaxolol Hydrochloride tablets recalled due to oxycodone contamination
FDA (Drugs) · 2023-10-25
- ModerateKVK-Tech Recalls Hydroxyzine Hydrochloride Tablets Due to Unapproved Ingredient Source
FDA (Drugs) · 2014-01-29